Differential adaptive responses of Staphylococcus aureus to in vitro selection with different antimicrobial peptides

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 10, 2013, Pages 5134-5137

  Shireen, Tahsina ^a   Singh, Madhuri ^a   Das, Tiyasa ^a,b   Mukhopadhyay, Kasturi ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GRAMICIDIN D; MAGAININ 2; MEMBRANE PHOSPHOLIPID; POLYPEPTIDE ANTIBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; IN VITRO SELECTION; INDUCED RESISTANCE; MEMBRANE BIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RIGIDITY; STAPHYLOCOCCUS AUREUS; VIRUS CULTURE; ZETA POTENTIAL;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; GRAMICIDIN; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PHOSPHOLIPIDS; STAPHYLOCOCCUS AUREUS;

EID: 84884243344     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00780-13     Document Type: Article

References (30)

1. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 24:389-395.
2. Hancock REW, Sahl H-G. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
3. Jacob L, Zasloff M. 1994. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found. Symp. 186: 197-223.
4. Eckert R. 2011. Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol. 6:635-651.
5. Giuliani A, Giovanna P, Nicoletto SF. 2007. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent. Eur. J. Biol. 2:1-33.
6. Gruenheid S, Moual HL. 2012. Resistance to antimicrobial peptides in gram-negative bacteria. FEMS Microbiol. Lett. 330:81-89.
7. Bell G, Gouyon P-H. 2003. Arming the enemy: the evolution of resistance to self-proteins. Microbiology 149:1367-1375.
8. Walsh TR, Howe RA. 2002. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu. Rev. Microbiol. 56:657-675.
9. Kaatz GW, Lundstrom TS, Seo SM. 2006. Mechanisms of daptomycin resistance in Staphylococcus aureus. Int. J. Antimicrob. Agents 28:280-287.
10. Perron GG, Zasloff M, Bell G. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273:251-256.
11. Pollard JE, Snarr J, Chaudhary V, Jennings JD, Shaw H, Christiansen B, Wright J, Jia W, Bishop RE, Savage PB. 2012. In vitro evaluation of the potential for resistance development to ceragenin CSA-13. J. Antimicrob. Chemother. 67:2665-2672.
12. Samuelsen Ø, Haukland HH, Jenssen H, Krämer M, Sandvik K, Ulvatne H, Vorland LH. 2005. Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. FEBS Lett. 579:3421-3426.
13. Tambe SM, Sampath L, Modak SM. 2001. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J. Antimicrob. Chemother. 47:589-598.
14. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th edition. Approved standard M7-A6. NCCLS, Wayne, PA.
15. Madhuri, Shireen T, Venugopal SK, Ghosh D, Gadepalli R, Dhawan B, Mukhopadhyay K. 2009. In vitro antimicrobial activity of alphamelanocyte stimulating hormone against major human pathogen Staphylococcus aureus. Peptides 30:1627-1635.
16. Singh M, Mukhopadhyay K. 2011. C-terminal amino acids of alphamelanocyte stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus. Antimicrob. Agents Chemother. 55:1920-1929.
17. Shireen T, Singh M, Dhawan B, Mukhopadhyay K. 2012. Characterization of cell membrane parameters of clinical isolates of Staphylococcus aureus with varied susceptibility to alpha-melanocyte stimulating hormone. Peptides 37:334-339.
18. Lakowicz JR. 2006. Principles of fluorescence spectroscopy, 3rd ed. Springer, New York, NY.
19. Wilson WW, Wade MM, Holman SC, Champlin FR. 2001. Status of methods for assessing bacterial cell surface charge properties based on zeta potential measurements. J. Microbiol. Methods 43:153-164.
20. Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, Sayama K, Hashimoto K, Kurihara H, Sugai M. 2005. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides,-defensins and LL-37, produced by human epithelial cells. J. Antimicrob. Chemother. 55:888-896.
21. Jones T, Yeamen MR, Sakoulas G, Yang S-J, Proctor RA, SahlH-G, Schrenzel J, Xiong YQ, Bayer AS. 2008. Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry and drug binding. Antimicrob. Agents Chemother. 52:269-278.
22. Mukhopadhyay K, Whitmire W, Xiong YQ, Molden J, Jones T, Peschel A, Staubitz P, Adler-Moore J, McNamara PJ, Proctor RA, Yeamen MR, Bayer AS. 2007. In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbial protein-1(tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. Microbiology 153: 1187-1197.
23. Xiong YQ, Mukhopadhyay K, Yeamen MR, Adler-Moore J, Bayer AS. 2005. Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3114-3121.
24. Bayer AS, Prasad R, Chandra J, Koul A, Smriti M, Varma A, Skurray RA, Firth N, Brown MH, Koo S-P, Yeamen MR. 2000. In vitro resistance of Staphylococcus aureus to thrombin-induced microbicidal protein is associated with alterations in membrane fluidity. Infect. Immun. 68:3548-3553.
25. Mishra NN, Liu GY, Yeamen MR, Nast CC, Proctor RA, McKinnell J, Bayer AS. 2011. Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob. Agents Chemother. 55:526-531.
26. Klein W, Weber MHW, Marahiel MA. 1999. Cold shock response of Bacillus subtilis: isoleucine-dependent switch in the fatty acid branching pattern for membrane adaptation to low temperatures. J. Bacteriol. 181: 5341-5349.
27. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, Kessel KPM, Strijp JAG. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor mprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 193:1067-1076.
28. Mishra NN, McKinnell J, Yeaman MR, Rubio A, Nast CC, Chen L, Kreiswirth BN, Bayer AS. 2011. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillinresistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 55:4012-4018.
29. Kilelee E, Pokorny A, Yeamen MR, Bayer AS. 2010. Lysyl- phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance. Antimicrob. Agents Chemother. 54:4476-4479.
30. Mishra NN, Bayer AS. 2013. Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57:1082-1085.